Earnings call transcript: Charles River beats Q3 2026 estimates but shares fall
Covered in this story
Analyst targets on Charles River Laboratories
- Jefferies: $295 → $340 by Sep 2027 · Buy via Investing.com UK
- JPMorgan: $266 → $310 by Aug 2027 · Overweight via Investing.com
- Evercore ISI: $261 → $300 by Aug 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Charles River Laboratories →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.